What's in Alcon Research's pipeline?

Alcon Research has 16 drugs in our index: 15 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Alcon Research's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alcon-research.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Alcon Research — Portfolio Competitive Intelligence Brief

Alcon Research pipeline: 15 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

15 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Area
Healon	Healon	marketed	Other
Travacom	Travacom	marketed	Other
Habitual prostaglandin monotherapy	Habitual prostaglandin monotherapy	marketed
Travoprost 0.004% BAK-free	Travoprost 0.004% BAK-free	marketed
Brinzolamide 1% ophthalmic suspension AZOPT®	Brinzolamide 1% ophthalmic suspension AZOPT®	marketed
Maxidex	Maxidex	marketed	Other
Nepafenac 0.1%	Nepafenac 0.1%	marketed
Apraclonidine Hydrochloride Ophthalmic Solution	Apraclonidine Hydrochloride Ophthalmic Solution	marketed
Fluticasone Propionate Nasal Spray, 50 mcg	Fluticasone Propionate Nasal Spray, 50 mcg	marketed
Triamcinolone Acetonide Injectable Suspension	Triamcinolone Acetonide Injectable Suspension	marketed
brinzolamide 1.0%	brinzolamide 1.0%	marketed
Brinzolamide 1% added to Travoprost 0.004%	Brinzolamide 1% added to Travoprost 0.004%	marketed

Therapeutic area mix

Other · 4
Cardiovascular · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Alcon Research:

Cite this brief

Drug Landscape (2026). Alcon Research — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alcon-research. Accessed 2026-05-13.